In the first of our new podcast – The RTW Podcast – we interview the CEO of Prometheus Biosciences, Mark McKenna , and RTW Investments Managing Director Research Analyst, Josh Kennedy-Smith about their work together.
In the episode they tell us about the white-knuckle ride that is building a pharmaceutical start-up, their passion for providing better care solutions for patients, the recent deal with Merck and the power of a strong partnership with your investor.
The episode is available on Spotify, Amazon Music and RSS.com
